The A to Z of medicines
Opportunity in Orphan Diseases to Get Involved
We would like to inform you that the European Commission’s DG Health has launched a call for expressions of interest to represent Patient Organisations in the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP).
All the relevant information is available on this link.
Should you be interested in applying, please make sure to do so by 20 December 2017 the latest.
All webinars all at once!
Easy to follow with thorough documentation: EUPATI webinars
Blogging with EUPATI
EUPATI at the 2017 ISPOR Conference
EUPATI Fellows, activists and patient experts participated at this year's ISPOR conference in Glasgow. This joint report from the participants describes their most important experiences. The EUPATI blog platform is there for all EUPATI Fellows and course participants to share their thoughts, proposals and questions. Send us an email if you would like to see your articles published and promoted.
The Alumni Network
A cohort of 100 patient experts with unparalleled experience
EUPATI graduates and patient experts have received deep and scientifically sound training in medicines development and clinical trials. They are also seasoned speakers and, many of them, trainers with first-hand experience in their respective therapeutic areas. Contact our Alumni Network if you want authentic and unbiased advice for your work or events.
Guidance documents on patient involvement in R&D
The European Patients’ Academy (EUPATI) guidance documents aim to support the integration of patient involvement across the entire process of medicines research and development with regulatory agencies, health technology assessment (HTA) bodies, ethics committees and the pharmaceutical industry.
Guidance for patient involvement in industry-led medicines R&D
This guidance document aims to support the integration of patient involvement in industry-led medicines R&D.
Guidance for patient involvement in regulatory processes
This guidance document aims to support the integration of patient involvement in regulatory processes.
Guidance for patient involvement in HTA
This guidance document aims to support the integration of patient involvement in HTA.
Guidance for patient involvement in ethical review of clinical trials
This guidance document aims to support the integration of patient involvement in the ethical review of clinical trials.
Mini-course starter kit – Protocol design
This EUPATI Mini-course starter kit is designed for patient involvement in protocol design.EUPATI Mini-course starter kits have been derived from content found in the EUPATI toolbox and EUPATI Patient Expert Training Course. The starter kits are thought to address roles that patients play in medicines development for example those shown in the figure showing the roadmap of patient involvement in medicine development.
Keep in touch and we'll send you updates by email
Steps of HTA processes and their necessary considerations
This fact sheet contains a list of the steps in the HTA process together with questions that should be considered during each of them.
Compensation in Clinical Trials
A presentation describing the compensation in clinical trials, which can be adapted for own use.
Patients Involved – Collaboration in an oncology trial
A French patient association (La Ligue contre le cancer – http://www.ligue-cancer.net/ ), developed a collaboration in oncology with....
All Aboard to a Better Health Future
This conference was held on the 14th of December 2016.
How did you adapt the Toolbox?
The EUPATI Toolbox is a fantastic new resource containing over 3000 pieces of content to help you learn more about the medicines research and development (R&D) process. Since its release in January 2016, tens of thousands of visitors from across Europe have been discovering, adapting and sharing tools to educate themselves and their patient communities. There are many different ways to use the EUPATI Toolbox, and we want to capture how different people in different countries are getting on.